Published in J Hepatol on May 01, 1999
Role of MRI in Detection of Minimal Hepatic Encephalopathy | NCT04131205
The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol (2011) 2.37
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut (2007) 2.09
Mechanisms, diagnosis and management of hepatic encephalopathy. Nat Rev Gastroenterol Hepatol (2010) 1.58
Prolonged remission from hepatic encephalopathy with rifaximin: results of a placebo crossover analysis. Aliment Pharmacol Ther (2014) 1.41
Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol (2008) 1.21
Diagnosis of Minimal Hepatic Encephalopathy Using Stroop EncephalApp: A Multicenter US-Based, Norm-Based Study. Am J Gastroenterol (2015) 1.01
Validation of EncephalApp, Smartphone-Based Stroop Test, for the Diagnosis of Covert Hepatic Encephalopathy. Clin Gastroenterol Hepatol (2014) 1.01
Introduction to the Hepatic Encephalopathy Scoring Algorithm (HESA). Dig Dis Sci (2007) 1.01
Quantitative multivoxel 1H MR spectroscopy of the brain in children with acute liver failure. Eur Radiol (2008) 0.92
Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag (2009) 0.90
Rifaximin versus Nonabsorbable Disaccharides for the Treatment of Hepatic Encephalopathy: A Meta-Analysis. Gastroenterol Res Pract (2013) 0.90
Engineering the gut microbiota to treat hyperammonemia. J Clin Invest (2015) 0.89
A current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol (2012) 0.88
Addition of adult-to-adult living donation to liver transplant programs improves survival but at an increased cost. Liver Transpl (2009) 0.87
Management of hepatic encephalopathy in the hospital. Mayo Clin Proc (2014) 0.85
Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure. Crit Care (2009) 0.84
Decreased heart rate variability in patients with cirrhosis relates to the presence and degree of hepatic encephalopathy. Am J Physiol Gastrointest Liver Physiol (2008) 0.84
A study on the position and etiology of infection in cirrhotic patients: A potential precipitating factor contributing to hepatic encephalopathy. Exp Ther Med (2013) 0.84
Nutrition and exercise in the management of liver cirrhosis. World J Gastroenterol (2014) 0.83
Change in model for end-stage liver disease score at two weeks, as an indicator of mortality or liver transplantation at 60 days in acute-on-chronic liver failure. Gastroenterol Rep (Oxf) (2014) 0.83
Metformin inhibits glutaminase activity and protects against hepatic encephalopathy. PLoS One (2012) 0.82
Minimal hepatic encephalopathy. Can J Gastroenterol (2013) 0.82
Acute-on-chronic liver failure: Pathogenesis, prognostic factors and management. World J Gastroenterol (2015) 0.82
Successful treatment for hepatic encephalopathy aggravated by portal vein thrombosis with balloon-occluded retrograde transvenous obliteration. Case Rep Gastroenterol (2011) 0.81
Portosystemic shunt syndrome and endovascular management of hepatic encephalopathy. Semin Intervent Radiol (2014) 0.80
Models for prediction of mortality from cirrhosis with special reference to artificial neural network: a critical review. Hepatol Int (2007) 0.80
Mini-Mental State Examination in patients with hepatic encephalopathy and liver cirrhosis: a prospective, quantified electroencephalography study. BMC Gastroenterol (2013) 0.80
Clinical and Pathophysiological Characteristics of Cirrhotic Patients with Grade 1 and Minimal Hepatic Encephalopathy. PLoS One (2016) 0.80
Nutritional assessment in cirrhotic patients with hepatic encephalopathy. World J Hepatol (2015) 0.79
Covert and Overt Hepatic Encephalopathy: Diagnosis and Management. Clin Gastroenterol Hepatol (2015) 0.79
Contribution of altered signal transduction associated to glutamate receptors in brain to the neurological alterations of hepatic encephalopathy. World J Gastroenterol (2006) 0.79
Evaluation of the impact of rehospitalization in the management of hepatic encephalopathy. Int J Gen Med (2015) 0.78
Breath-ammonia testing of healthy subjects and patients with cirrhosis. Dig Dis Sci (2011) 0.78
A capillary blood ammonia bedside test following glutamine load to improve the diagnosis of hepatic encephalopathy in cirrhosis. BMC Gastroenterol (2011) 0.78
Overt hepatic encephalopathy in Italy: clinical outcomes and healthcare costs. Hepat Med (2015) 0.78
Liver transplantation in adults: Choosing the appropriate timing. World J Gastrointest Pharmacol Ther (2012) 0.77
Prognostic index of cirrhotic patients with hepatic encephalopathy with and without hepatocellular carcinoma. Dig Dis Sci (2004) 0.76
Reduced cortical thickness in patients with acute-on-chronic liver failure due to non-alcoholic etiology. J Transl Med (2015) 0.76
Saccadic latency in hepatic encephalopathy: a pilot study. Metab Brain Dis (2010) 0.76
Contemporary Understanding and Management of Overt and Covert Hepatic Encephalopathy. Gastroenterol Hepatol (N Y) (2016) 0.76
Cytokine levels contribute to the pathogenesis of minimal hepatic encephalopathy in patients with hepatocellular carcinoma via STAT3 activation. Sci Rep (2016) 0.76
A neurotoxic alcohol exposure paradigm does not induce hepatic encephalopathy. Neurotoxicol Teratol (2016) 0.75
Managing complications in cirrhotic patients. United European Gastroenterol J (2015) 0.75
Evaluation and Management of Hepatic Encephalopathy: Current Status and Future Directions. Gut Liver (2016) 0.75
Frequency of minimal hepatic encepalopathy in illeterate patients with compensated cirrhosis. Pak J Med Sci (2016) 0.75
Predictors of hospital re-admissions among Hispanics with hepatitis C-related cirrhosis. Ann Gastroenterol (2016) 0.75
The extrahepatic consequences of cirrhosis. MedGenMed (2006) 0.75
Management of covert hepatic encephalopathy. J Clin Exp Hepatol (2014) 0.75
Liver transplantation and autoimmune hepatitis. Intractable Rare Dis Res (2015) 0.75
Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosis. Medicine (Baltimore) (2017) 0.75
Advances in cirrhosis: Optimizing the management of hepatic encephalopathy. World J Hepatol (2015) 0.75
Hepatic encephalopathy: early diagnosis in pediatric patients with cirrhosis. Iran J Child Neurol (2014) 0.75
Hepatic Encephalopathy: An Update on the Pathophysiology and Therapeutic Options. J Clin Transl Hepatol (2017) 0.75
Disrupted topological organization of brain structural network associated with prior overt hepatic encephalopathy in cirrhotic patients. Eur Radiol (2017) 0.75
MELD score does not discriminate against patients with hepatic encephalopathy. Dig Dis Sci (2005) 0.75
Validation of a Paper and Pencil Test Battery for the Diagnosis of Minimal Hepatic Encephalopathy in Korea. J Korean Med Sci (2017) 0.75
Pathophysiology, diagnosis, and management of hepatic encephalopathy. Inflammopharmacology (2014) 0.75
Economic impact of the use of rifaximin 550 mg twice daily for the treatment of overt hepatic encephalopathy in Italy. Hepat Med (2017) 0.75
Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol (2001) 19.07
Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma. Hepatology (2001) 6.88
Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal haemorrhage in patients with cirrhosis. Lancet (1995) 6.06
Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med (1999) 5.89
Natural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trials. Hepatology (1999) 5.64
Peripheral arterial vasodilation hypothesis: a proposal for the initiation of renal sodium and water retention in cirrhosis. Hepatology (1988) 4.32
The impact of placental malaria on gestational age and birth weight. J Infect Dis (2000) 4.25
Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution. Hepatology (1998) 3.62
Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J Hepatol (2000) 3.43
Incidence, predictive factors, and prognosis of the hepatorenal syndrome in cirrhosis with ascites. Gastroenterology (1993) 3.28
Compensated cirrhosis: natural history and prognostic factors. Hepatology (1987) 3.01
Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology (1990) 2.99
Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure. Gastroenterology (1996) 2.96
Placental pathology in malaria: a histological, immunohistochemical, and quantitative study. Hum Pathol (2000) 2.84
Bacterial translocation of enteric organisms in patients with cirrhosis. J Hepatol (2001) 2.73
Effects of somatostatin on renal function in cirrhosis. Gastroenterology (1992) 2.68
Angiotensin II induces contraction and proliferation of human hepatic stellate cells. Gastroenterology (2000) 2.57
Treatment of hepatocellular carcinoma with tamoxifen: a double-blind placebo-controlled trial in 120 patients. Gastroenterology (1995) 2.47
Cyclosporin A treatment in primary biliary cirrhosis: results of a long-term placebo controlled trial. Gastroenterology (1993) 2.32
Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study. Gastroenterology (1990) 2.31
Renal impairment after spontaneous bacterial peritonitis in cirrhosis: incidence, clinical course, predictive factors and prognosis. Hepatology (1994) 2.27
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma. J Hepatol (2000) 2.22
S-adenosylmethionine in alcoholic liver cirrhosis: a randomized, placebo-controlled, double-blind, multicenter clinical trial. J Hepatol (1999) 2.14
Clinical events after transjugular intrahepatic portosystemic shunt: correlation with hemodynamic findings. Gastroenterology (1998) 2.10
Massive chronic intervillositis of the placenta associated with malaria infection. Am J Surg Pathol (1998) 2.05
Randomized, comparative study of oral ofloxacin versus intravenous cefotaxime in spontaneous bacterial peritonitis. Gastroenterology (1996) 2.00
Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology (1993) 1.97
Beta-blockade with propranolol and hepatic artery blood flow in patients with cirrhosis. Hepatology (1989) 1.97
Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club. Gut (2005) 1.93
Circulating levels of endothelin in cirrhosis. Gastroenterology (1993) 1.91
Hepatopulmonary syndrome in candidates for liver transplantation. J Hepatol (2001) 1.89
Transjugular intrahepatic portosystemic shunt in hepatorenal syndrome: effects on renal function and vasoactive systems. Hepatology (1998) 1.87
Comparison of rifampicin with phenobarbitone for treatment of pruritus in biliary cirrhosis. Lancet (1989) 1.86
Delayed introduction of reduced-dose tacrolimus, and renal function in liver transplantation: the 'ReSpECT' study. Am J Transplant (2008) 1.86
Placental malaria is associated with cell-mediated inflammatory responses with selective absence of natural killer cells. J Infect Dis (2001) 1.84
Histological course of alcoholic hepatitis. Influence of abstinence, sex and extent of hepatic damage. J Hepatol (1986) 1.84
Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognostic power. Hepatology (1998) 1.83
Impaired responsiveness to angiotensin II in experimental cirrhosis: role of nitric oxide. Hepatology (1993) 1.79
Comparison of transcriptional and blood cell-phenotypic markers between operationally tolerant liver and kidney recipients. Am J Transplant (2011) 1.78
Effects of silymarin in alcoholic patients with cirrhosis of the liver: results of a controlled, double-blind, randomized and multicenter trial. J Hepatol (1998) 1.76
Prognostic value of arterial pressure, endogenous vasoactive systems, and renal function in cirrhotic patients admitted to the hospital for the treatment of ascites. Gastroenterology (1988) 1.76
Atrial natriuretic factor in cirrhosis with ascites: plasma levels, cardiac release and splanchnic extraction. Hepatology (1988) 1.74
Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology (1988) 1.73
Reticuloendothelial system phagocytic activity in cirrhosis and its relation to bacterial infections and prognosis. Hepatology (1984) 1.73
Multiparameter immune profiling of operational tolerance in liver transplantation. Am J Transplant (2007) 1.69
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology (1996) 1.68
Hepatitis C virus antibodies in chronic alcoholic patients: association with severity of liver injury. Hepatology (1990) 1.67
Hemodynamic and humoral changes after liver transplantation in patients with cirrhosis. Hepatology (1993) 1.67
Fulminant hepatic failure. Lancet (1997) 1.66
In vitro and in vivo activation of rat hepatic stellate cells results in de novo expression of L-type voltage-operated calcium channels. Hepatology (2001) 1.66
Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology (1999) 1.64
Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: results of a double-blind, placebo-controlled trial. Hepatology (1990) 1.63
Desensitization to the effects of intravenous octreotide in cirrhotic patients with portal hypertension. Gastroenterology (2001) 1.62
Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: relationship with the development of renal impairment and mortality. Hepatology (1998) 1.60
Prognostic value of spontaneous hyponatremia in cirrhosis with ascites. Am J Dig Dis (1976) 1.59
Is hepatitis C virus infection a trigger of porphyria cutanea tarda? Lancet (1993) 1.57
Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology (1992) 1.57
Prevalence of the Cys282Tyr and His63Asp HFE gene mutations in Spanish patients with hereditary hemochromatosis and in controls. J Hepatol (1998) 1.55
Applicability and results of Maastricht type 2 donation after cardiac death liver transplantation. Am J Transplant (2011) 1.54
Increased nitric oxide-dependent vasorelaxation in aortic rings of cirrhotic rats with ascites. Hepatology (1994) 1.54
Antibodies against the COOH-terminal region of E. coli ClpP protease in patients with primary biliary cirrhosis. J Hepatol (2000) 1.53
Steady-state extrarenal sorbitol clearance as a measure of hepatic plasma flow. Gastroenterology (1988) 1.53
Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology (1990) 1.52
Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections. Hepatology (1985) 1.50
Cyclosporine-associated mutism in liver transplant patients. Neurology (1996) 1.49
Metadoxine accelerates fatty liver recovery in alcoholic patients: results of a randomized double-blind, placebo-control trial. Spanish Group for the Study of Alcoholic Fatty Liver. J Hepatol (1998) 1.49
Cross-reactivity of anti-Mycobacterium gordonae antibodies with the major mitochondrial autoantigens in primary biliary cirrhosis. J Hepatol (1994) 1.49
A prognostic model for predicting survival in cirrhosis with ascites. J Hepatol (2001) 1.49
Endoscopic sclerotherapy in upper gastrointestinal bleeding due to the Mallory-Weiss syndrome. Am J Gastroenterol (1994) 1.48
[Massive pleural effusion secondary to pancreatic-pleural fistula as first manifestation of chronic pancreatitis. Report of three cases]. Med Clin (Barc) (1997) 1.43
Limitations of laser-Doppler velocimetry and reflectance spectrophotometry in estimating gastric mucosal blood flow. Am J Physiol (1992) 1.43
Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis. Gastroenterology (1997) 1.43
Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Hepatology (1992) 1.42
Recurrence of spontaneous bacterial peritonitis in cirrhosis: frequency and predictive factors. Hepatology (1988) 1.40
Efficacy of balloon tamponade in treatment of bleeding gastric and esophageal varices. Results in 151 consecutive episodes. Dig Dis Sci (1988) 1.40
Renal insensitivity to atrial natriuretic peptide in patients with cirrhosis and ascites. Effect of increasing systemic arterial pressure. Gastroenterology (1992) 1.40
[Comparative analysis of articles published by Spanish authors (1993-1997) in biomedical journals with high impact factor]. Med Clin (Barc) (2000) 1.39
[138 episodes of bacteremia or fungemia in patients with solid organ (renal or hepatic) transplantation]. Med Clin (Barc) (1994) 1.39